OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients
Abroad (travel likely)RecruitingPHASE2
Conditions
COVID-19 · Immunodeficiency
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Basel University Hospital, Basel, Basel, Switzerland
Hôpitaux Universitaires de Genève, Geneva, Canton of Geneva, Switzerland
CHUV, Lausanne, Canton of Vaud, Switzerland
University Hospital Zurich, Zurich, Canton of Zurich, Switzerland
Study leads
Alexandra Calmy, MD PhD
Principal Investigator
Hopitaux Universitaires de Genève
Nina Khanna, MD PhD
Principal Investigator
Basel University Hospital
Nicolas Muller, MD PhD
Principal Investigator
University of Zurich
Oriol Manuel, MD PhD
Principal Investigator
University Hospital CHUV